6-azaindole has been researched along with HIV Coinfection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carini, DJ; Hamann, LG; Johnson, K; Li, W; Lin, PF; Liu, Z; Meanwell, NA; Parker, DD; Rahematpura, S; Regueiro-Ren, A; Swidorski, JJ; Wang, T; Yin, Z; Zhang, S; Zheng, M | 1 |
1 other study(ies) available for 6-azaindole and HIV Coinfection
Article | Year |
---|---|
Inhibitors of HIV-1 attachment: The discovery and structure-activity relationships of tetrahydroisoquinolines as replacements for the piperazine benzamide in the 3-glyoxylyl 6-azaindole pharmacophore.
Topics: Aza Compounds; Benzamides; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; HeLa Cells; HIV Envelope Protein gp120; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Indoles; Molecular Structure; Piperazines; Structure-Activity Relationship; Tetrahydroisoquinolines; Virus Attachment; Virus Replication | 2016 |